Today we bring you the new product from FLASH HEART, FLASH HEART BABY 2000 PUFF.
FLASH HEART shows up in front of people often in the past two years,
From the first compatible disposable to the hot-selling 1500puff disposable vape last year,
Whether it’s flavors or taste, they all bring vapers a very good experience.
Now let’s go on to find out how the FLASH HEART BABY 2000 PUFF is.
FLASH HEART BABY 2000 PUFF specifications
Nicotine content: 3%
Package content: 9 pcs in a box
FLASH HEART BABY 2000 PUFF flavors
FLASH HEART BABY 2000 PUFF advantages
1. FLASH HEART style flavors, very unique and comfortable to vape
2. Upper-middle level taste as always
3. Long battery life, 2000 puffs.
FLASH HEART BABY 2000 PUFF downsides
1. The taste is more granular, which is a small problem of the straight-through design, too sweet. And there is condensation.
2. The golden ring in the middle looks not coordinated.
3. This 2000 puff design doesn’t come with a replaceable mouthpiece.
4. The air intake at the bottom is not adjustable
5. Not portable enough.
FLASH HEART BABY 2000 PUFF didn’t bring me many surprises this time.
The taste of Libina juice and Banana is the best including the overall feeling.
The feeling of banana is different from the taste of other brands, which is very good.
Many fans of Captain Dirty speak highly of Libina flavor.
However, the overall sweetness of the new flavor is high.
Captain reported it to the brand side, and there will be qualitative changes later.
And there will be more flavors in the later stage, we’re looking forward to it
Okay, I’m Captain Dirty.
VAPE HOW WE ROLL
ALL IN TRUE TOY
See you next time!
The U.S. International Trade Commission (ITC) has found that Philip Morris International’s IQOS heated tobacco product violates British American Tobacco patents, and therefore imports of the device to the United States are illegal. The ban will take effect in 60 days.
The ruling, which affirmed a preliminary decision from earlier this year, applies to imported devices sold within the U.S. The Biden administration’s U.S. Trade Representative could overrule the trade agency’s decision, but that happens rarely, according to Bloomberg News. The ITC supported BAT’s patent claims during the trial.
Altria is expected to file an appeal in the U.S. Court of Appeals, but the ban would remain in place until the appeals court decides the case, which could take up to a year. Another possible route for Altria/PMI, according to the Tobacco Reporter, would be to shift IQOS production to the U.S., since the decision only applies to imports. IQOS is manufactured in Europe and Asia.
IQOS has been authorized by the FDA for sale in the U.S. under both the Premarket Tobacco Application (PMTA) and Modified Risk Tobacco Product (MRTP) pathways. It has been sold here since 2019 in limited markets by Altria, which has licensed the product from PMI for U.S. sales. It is currently available only in Georgia, North Carolina, South Carolina and Virginia.
The ITC found that IQOS violates two patents held by Reynolds American Inc. (RAI—the former RJ Reynolds), which is now a subsidiary of international tobacco giant BAT. Since the IQOS dispute began, Reynolds and PMI/Altria have filed multiple lawsuits against each other in federal courts, both claiming infringement of various patents. BAT has also unsuccessfully challenged IQOS patents in European courts.
Heated tobacco products (HTPs) heat tobacco to a temperature too low to combust but high enough to create a nicotine-containing vapor inhaled by the user. HTPs are sometimes called heat-not-burn (HNB) products.
Smokers created vaping without any help from the tobacco industry or anti-smoking crusaders, and vapers have the right to keep innovating to help themselves. My goal is to provide clear, honest information about the challenges vaping faces from lawmakers, regulators, and brokers of disinformation. I recently joined the CASAA board, but my opinions aren’t necessarily CASAA’s, and vice versa. You can find me on Twitter @whycherrywhy
The letter asks the WHO to end its war on vaping and other alternatives to smoking, which have been identified by science as effective smoking cessation tools. Discussing the letter, Michael Landl, the director of the World Vapers’ Alliance (WVA), one of the organisations behind the letter, explained that millions of lives could be saved if the WHO would change its stance.
“The WHO has an opportunity to beat smoking for good but instead they choose to turn their guns on vaping and other tools that can reduce the harm of tobacco. The WHO routinely ignores the wealth of scientific evidence pointing to the benefits of these products and the first-hand experience of millions of citizens who have quit smoking for good. Restricting or banning access to vaping, nicotine pouches, snus, and other products will do nothing but cost lives. Millions of lives could be saved if the WHO was really serious about beating smoking.”
The COP9’s Framework Convention on Tobacco Control protocol
The WHO’s global ‘COP 9’ conference, taking place this November, is known to be blindly against vaping and is tragically known to have a great influence on anti-smoking and vaping policies worldwide. Sadly, the COP9’s Framework Convention on Tobacco Control (FCTC) protocol is know to have lost sight of its core objective of reducing smoking, and has become increasingly focused on fighting access to less harmful alternatives that are actually helping millions of smokers worldwide quit smoking.
“200 million lives worldwide could be saved, but as it stands it looks like COP9 will be another anti-science and anti-consumer WHO charade. It is time to actually deliver on the FCTC commitment to tobacco harm reduction by endorsing harm reduction products,” said Landl.
Anti-THR events in Asia
Meanwhile in Asia, in the lead up to the 13th Asia Pacific Conference on Tobacco or Health (APACT) which took place virtually from Bangkok earlier this month, the 11 members of organizations of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), signed a declaration promoting THR.
“September marks the start of the secret season which sadly sees supposed ‘tobacco control experts’ playing up to their puppet masters and denying Asia Pacific’s 600 million smokers’ access to safer nicotine products,” said CAPHRA Executive Coordinator Nancy Loucas.
APACT presented a line up of speakers renowned for their irrational stance on THR. “APACT has wheeled out a totally predictable programme and line up of speakers who share an irrational and untenable position against safer nicotine products such as vaping. Also, in common is that many, if not most, are longtime Bloomberg grant recipients or indirect beneficiaries. Preaching to themselves in their echo chamber, they continue to ignore all the science and the harm they are causing consumers,” explained Loucas.
SEARO and WPRO
While a few days later, the WHO’s South East Asia Regional Office (SEARO) also held its online regional conference, from 6 to 10 September, with the Western Pacific for their Regional Office (WPRO) following from 25 to 29 October.
Discussing these major events, the Asia Pacific Declaration expressed its concern with regards to the influence they will exert on the region’s policy makers. “We are extremely concerned that decisions are being made in various conferences and regional meetings that are not considering the body of scientific evidence that proves the benefits of safer nicotine products.”
Chicago has allowed 18 adult-use cannabis retailers so far, among the 110 statewide.
The move will allow recreational marijuana stores to expand further than the current seven marijuana zones in the municipality. The largest in the state of Illinois, Chicago has allowed 18 adult-use cannabis retailers so far, among the 110 statewide.
While marijuana retailers are now able to open without special approval from Chicago regulators, the approved proposal is also set to banish retailers in the downtown zone where they aren’t meant to be operating.
Concerns about use by minors in NYC
Meanwhile in the city of New York, State Governor Andrew Cuomo and legislative leaders agreed to legalize and decriminalize recreational marijuana for adults who are 21 and older, last April. Less than two months after the measure was passed, the state of New York followed suit. However, the New York Post reported that DOH Chief Medical Officer Michelle Morse emailed NYC health officials warning them about a concerning increase in students smoking weed.
Dr. Cathy Ward, a pediatrician with Big Apple Pediatrics said that many teens have shifted from vaping to smoking pot, in line with the availability of flavours. “A lot of them have shifted over to weed, just smoking pot,” she said. “And a lot of them were smoking e-cigarettes and hookah and Juul. I think its availability is been appealing to them. It’s got the different flavors and it’s being marketed to them. So I think that’s why it’s kind of all shifted.”
Ward said that doctors should take a proactive approach and have conversations about smoking during routine check-ups with kids. She added that one way to find out whether they smoke, would asking them about their friends’ habits.
San Jose, California has become the largest U.S. city to ban all flavored tobacco and vaping products after a unanimous city council vote Tuesday night. The ban covers vaping products in all flavors except tobacco, menthol cigarettes and smokeless tobacco, but exempts hookah products.
The ban will take effect June 30, 2022. San Jose, considered the “capital of Silicon Valley,” is home to just over a million residents. The city has more than 650 tobacco and vaping retailers, according to the San Jose Mercury News.
While San Jose is the largest and most recent U.S. city to ban all flavored tobacco and vaping products, more than 100 California cities have similar laws, including San Jose’s Bay Area neighbors San Francisco and Oakland. Many others have banned flavored vaping products only, as have cities in other states, and four states.
If you’re new to vaping, you may not be familiar with the terms ‘mouth to lung’ (MTL) and ‘direct to lung’ (DTL). Essentially, MTL and DTL describe how you inhale the vapour in your e-cigarette.
It’s important to research what the difference is between Mouth to lung vs direct to lung vaping before buying a vape kit or e-cigarette to make sure you purchase the best product for your vaping style. Let’s explore the two different styles.
Mouth to Lung (MTL) Explained
Mouth to lung vaping is inhaling the vapour created by your e-cigarette through your mouth and then into your lungs. It’s more similar in style to cigarette smoking, making it a great option for vaping beginners looking to transition off cigarettes and on to e-cigarettes.
How to Pick an MTL Vape Kit
Vape kits designed for MTL vaping have a higher resistance coil. The coil is the atomiser inside the e-cigarette that is responsible for vapourising the e-liquid inside. The coil resistance is measured in ohms. MTL vaping kids normally have a resistance of at least 1 ohm, meaning the e-liquid is vapourised at a lower temperature, creating a smaller amount of vapour. MTL kits replicate tobacco smoking, creating a similar amount of vapour as smoke from a traditional cigarette.
Choosing the Right e-liquid for your Mouth to Lung Vaping Kit
E-liquids contain a ratio of propylene glycol and vegetable glycerine (indicated on the packaging). It’s important to choose an e-liquid that is compatible with your MTL vaping kit. If you use an e-liquid with the wrong ratio of propylene glycol or vegetable glycerine, you run the risk of shortening the lifespan of the coils inside your vaping kit, not to mention experiencing a burnt taste from your vaper. As a general rule of thumb, try to choose an e-liquid with 50% propylene glycol and 50% vegetable glycerine in your MTL vaping kit.
Advantages of MTL Vaping
Here are some reasons why people choose MTL vaping kits over DTL vaping.
Easy to use
Cheaper than DTL vaping kits and use less vape juice
Very similar to smoking, making it great to transition off cigarettes
MTL kits accentuate the flavour of your e-liquid
Direct to Lung (DTL) Vaping Explained
DTL vaping (also referred to as ‘sub ohm’) is a different style of vaping that involves inhaling e-cigarette vapour directly into the lungs. Unlike MTL vaping which replicates cigarette smoking, DTL is more like taking a normal breath. The vapour produced by a DTL vaping kit is thicker and warmer, making it more suitable for experienced vapour. Having said that, there are some great, easy-to-use ‘sub ohm’ kits for beginners who want to try DTL vaping.
How to Pick a DTL Vape Kit
As we learned above, the resistance of the coils within a vaping kit is measured in ohms. While an MTL kit usually has a resistance of at least 1 ohm, DTL vaping kits have coils with a resistance below 1 ohm. Thanks to the lower resistance, DTL kits can heat the e-liquid to a hotter temperature, creating thicker, warmer vapour. DTL vaping kits are generally larger and more complicated to use than MTL kits, boasting an LED screen and a range of settings to customise your vaping experience. While these extra features are great for an experienced vaper, they could be a little overwhelming for beginners.
Choosing the Right e-Liquid for your Direct To Lung Vaping Kit
Always choose an e-liquid with a lower nicotine level when using DTL or ‘sub ohm’ vape kits. DTL kits produce more vapour, so it’s best to choose a less nicotine-rich e-liquid (3mg is a good starting point) to avoid getting an excessively strong hit of nicotine. It’s also recommendable to choose an e-liquid with at least 50% Vegetable Glycerine (VG) and a maximum of 50% Propylene Glycol (PG). Generally speaking, e-liquids with over 50% PG will be very harsh when used in a DTL vape kit.
Advantages of DTL Vaping
DTL kits have more features and settings, for a more personalised vaping experience
The denser vapour means that you get more nicotine with each inhalation, making it easier to switch to a lower strength e-liquid
It creates a thicker cloud of warmer, smoother vapour, which many people prefer
If you vape regularly or you’re considering taking up vaping, it’s important to know the difference between MTL and DTL vaping. Choosing the right vaping style will make vaping a more enjoyable experience and ensure that you choose the best products to use with your vape kit to maintain your device for as long as possible.
In December 2020, Health Canada proposed a nicotine limit of 20 milligrams per milliliter (mg/ml) for all vaping products. This proposal came in response to a flawed paper published on BMJ, concluding that in Canada there was an increase in youth vaping and subsequent smoking. And while almost a year later, the inaccuracies in the study were acknowledged and the journal issued a correction, Canadian authorities have not changed direction accordingly.
The new limit, came into effect on July 8th, and also includes a regulation that prohibits Canadian manufacturers from exporting products that exceed a nicotine concentration of 66 mg/ml. On top of that, a recent press release by the Canadian Vaping Association (CVA) revealed that the Canadian Government has proposed a ban on vape flavours with the exception of tobacco, mint, and menthol.
Proposals by Health Canada
Another release by public health expert Clive Bates, shared the pending proposals:
“Health Canada, Consultation: Proposed vaping products’ flavour regulations and order, June 2021 [link]
Health Canada, Regulatory Impact Analysis Statement, June 19, 2021. [link]
Health Canada, Tobacco Control Directorate / Cannabis Cost-Benefit Analysis Team, Cost-Benefit Analysis, June 2021 [access]
Industrial Economic Incorporated, Elicitation of Expert Judgements on the Behavioural Impacts of a Nicotine Standard. A report for Tobacco Products Regulatory Office, Health Canada, March 2017. [access].”
In line with actual data from places where such measures have already been implemented, Bates highlights that this is the nearest authorities can get to a prohibition without fully banning the safer alternatives to cigarettes. “The likely effects are obvious: more smoking. But in a bizarre twisting of reality and evidence, Health Canada finds that making vaping less attractive relative to smoking will… um … reduce smoking. And that’s how it justifies the measure.”
Young adults are quitting smoking thanks to vaping
Bates and three other renowned fellow experts in the field of tobacco harm reduction, responded to Health Canada’s submission. Meanwhile, recent figures released by Statistics Canada, have indicated that Canadians in their twenties are actually quitting smoking at an unprecedented rate thanks to vaping.
The Canadian Tobacco and Nicotine Survey has indicated that between 2019 and 2020, there was a 40% drop in smoking rates in this specific age group, from 13.3% to 8%. This figure makes Health Canada’s no smoking target (5% by 2035) seem achievable. Moreover this 5% target rate has already been reached among those aged 15-19.
The media remains selective in what it reports
In a letter addressed to Health Minister Patty Hajdu, professor of Economics at Concordia University, and a research fellow at the C.D. Howe Institute, Ian Irvine, said that it shameful that the media is selective in what it reports. “It is unfortunate that these achievements have been largely ignored by a media that has been, for the most part, fixated on the concept of a vaping epidemic among these age groups.”
Irvine highlighted that while smoking rates had been declining due to Government policy towards tobacco, the real change happened when vaping products arrived on the scene. “By 2013 smoking had declined to 11 percent for those aged 15-19, 18 percent for 20-24 year olds, and about 16 percent for those aged 25 and above…Then a disruptive technology intruded on the scene –vaping.”
A more consistent vapour experience that competes with combustible cigarettes
A newly designed JUUL Device with a larger, long-lasting battery, and smart light system, communicating e-liquid level and battery life
Newly designed Tobacco and Menthol JUUL2 pods (18 mg/mL nicotine strength)
Technology to prevent unauthorized use, such as the inclusion of JUULpod ID to further combat against counterfeit pods.
The JUUL2 can only be purchased from the company’s website, with a UK retail roll out in 2022.
JUUL says anyone purchasing the device online will go through a scrupulous age-verification process to include photo ID.
New tech also means it will be easier for JUUL to spot the counterfeits that have been flooding the market, and only JUUL2 pods will work with the new device.
Juul Labs’ EMEA VP, Dan Thomson said:
We are pleased to launch the next-generation JUUL2 in the UK.
A key part of our mission is to transition adult smokers away from cigarettes, the leading cause of preventable death in the world, killing some 90,000 Britons annually.
We believe the best method to switch adult smokers from combustible cigarettes to a potentially less harmful, non-combustible alternative, is to provide a product that closely resembles the consistency and experience of smoking.
With JUUL2, we believe we are taking another step in that direction as we aim to transition even more adult smokers.
It will be very interesting to see how it vapes and indeed how the sales go on these shores.
I wrote the original JUUL review, with the flavoured pods and felt it was a little under-powered and under-flavoured.
I have reached out to JUUL for a sample to be sent for review…watch this space as they say…
The JUUL2 exclusive UK launch is this Thursday – September 30th.
Will you be one of the first to buy the JUUL2 kit?
Do let me know in the comments below…
GeekVape’s New Fast Charging Gets the Green Light
Geekvape’s new Safe Fast Charge technology has passed the most stringent of safety tests.
The new tech means e-cigarettes can be charged within 15 minutes using the Type-C USB cable and the experts say it will also mean longer battery longevity.
This fast charging technology is the first in the world and scientists from the German based Technischer Überwachungsverein (TÜV) – Technical Inspection Association – carried out rigorous testing and said:
Geekvape’s Safe Fast Charge technology achieved 96.43% charging current and battery capacity after more than 300 rounds of TÜV charging and discharging tests — far outperforming the international standard of 80%.
As you’d expect, the company was delighted and Siner Kong, the product manager of Geekvape said:
At Geekvape, we adhere only to the most stringent global safety standards.
Our Safe Fast Charge technology has been strictly tested by leading independent parties, including the TÜV and FCC.
As a result, we can confidently say we have achieved the world’s first fast-charging e-cigarette technology that is truly safe and durable.
In addition to TÜV tests, Geekvape’s Safe Fast Charge technology has passed IEC61960 and ICE62133 global battery safety regulation standards.
Great news and even better news for the company after it cleaned up at the recent Vapouround Awards 2021.
Geekvape won five trophies: Best Branding and Marketing, Industry Leader, Best Mod (Legend2), Best Tank (DF Drop RDA V1.5) and Best Disposable (Geekbar, its disposable e-cigarette device).
High fives all round 😉
Disinformation Around Vaping STILL Stopping Smokers Switch
Smokers around the world are still confused about the safety of e-cigarettes thanks to the sheer amount of false, fake and misleading information.
A survey carried out by Big Tobacco company Phillip Morris Inc [PMI] shows almost half of those surveyed believed HNB and vaping was as if not more dangerous than smoking.
PMI is of course the manufacturer of iconic lit tobacco brand Marlboro.
However, over the past few years it has shifted to both Heat Not Burn with the IQOS and and the IQOS Mesh kit that takes e-liquid.
The survey targeted 30,000 people from 26 countries and the results are shocking to say the least – PMI says:
Nearly half the adults surveyed wrongly believe that e-cigarettes and heated tobacco products are more harmful than or equally harmful as cigarettes (45% and 46%, respectively, for each product category).
Asked why they have not considered switching to a better alternative, around a third of smokers surveyed cited lack of information about how these products differ from cigarettes (33%), uncertainty about the science (35%), or having easier access to cigarettes (32%), the most harmful form of tobacco consumption.
Grégoire Verdeaux, Senior Vice President, External Affairs at PMI, said:
People expect public health bodies and regulators to reach a scientific consensus around innovative smoke-free alternatives and provide adults who smoke with evidence-based information about these products.
Misinformation about smoke-free alternatives—often based on opinion—is a persistent issue that is having real-world consequences.
Embracing facts, innovative technologies, and science is the shared responsibility of industry, health authorities, and government, and it’s the least we can do to drive positive change for the world.
At Philip Morris International, we prioritize transparency as we transform our business to deliver a smoke-free future—inviting policymakers, the scientific community, and NGOs to review and verify our scientific findings.
By providing adult smokers science-based information about better alternatives, we can accelerate the decline in smoking rates, helping to end the use of cigarettes once and for all.
It’s not the first survey to show the anti-vape brigade’s lies are having a major impact and I doubt it will be the last.
The findings do not mean that no such effect exists, but that this study found no strong evidence of it.
A recent clinical practice guideline on treatments for tobacco dependence in adults by the American Thoracic Society (ATS) included the use of the drug as part of the Grading of Recommendations, Assessment, Development, and Evaluation, or GRADE, approach:
“For tobacco-dependent adults in whom treatment is being initiated, we recommend varenicline over a nicotine patch (strong recommendation, moderate certainty in the estimated effects).
For tobacco-dependent adults in whom treatment is being initiated, we recommend varenicline over bupropion (strong recommendation, moderate certainty in the estimated effects).
For tobacco-dependent adults in whom treatment is being initiated, we suggest varenicline plus a nicotine patch over varenicline alone (conditional recommendation, low certainty in the estimated effects).
For tobacco-dependent adults in whom treatment is being initiated, we suggest varenicline over electronic cigarettes (conditional recommendation, very low certainty in the estimated effects).
In tobacco-dependent adults who are not ready to discontinue tobacco use, we recommend that clinicians begin treatment with varenicline rather than waiting until they are ready to stop tobacco use (strong recommendation, moderate certainty in estimated effects).
For tobacco-dependent adults with co-morbid psychiatric conditions, including substance use disorder, depression, anxiety, schizophrenia and/or bipolar disorder, for whom treatment is being initiated, we recommend varenicline over a nicotine patch (strong recommendation, moderate certainty in estimated effects).
For tobacco-dependent adults for whom treatment is being initiated with a controller, we recommend using extended duration (greater than 12 weeks) over standard duration (6-12 weeks) (strong recommendation, moderate certainty in estimated effects).”
The research failed to identify a ‘statistically significant’ difference between the rate of psychiatric adverse events in people given varenicline and those given an inactive placebo. This of course does not mean that no such effect exists, but that this study found no strong evidence of it.
Lead study author Dr. Emma Beard (UCL Behavioural Science and Health), who led the analysis, said that the bad reputation of the drug has been putting many lives at risk. “The shadow of psychiatric problems has arguably cost thousands of lives by putting people off using Varenicline to help them stop, and doctors off prescribing it. This analysis should provide further reassurance to smokers and clinicians that this is a safe, life-saving drug.”
The Saudi launch of RELX, which is one of the biggest manufacturers, distributors and sellers of vaping products in China, comes as local concerns about teen vaping are starting to increase. To this effect the kingdom has recently announced new regulations similar to those in Europe, with regards to e-cigarette packaging and labeling.
Last year Saudi Customs banned the importation of shisha and vaping products through shipping companies and individuals’ websites, from now on allowing only licensed companies to import the products for commercial purposes.
Commenting on the brand’s launch in Saudi, Fouad Barakat, the local general manager at RELX International, explained the financial logic behind the move. “The MENA region is one of our category’s fastest-growing markets, growing at a rate just short of 10 percent until 2024. Saudi Arabia is one of the region’s largest and most prosperous markets, hence the need for any brand to launch there if it wants to thrive and grow bigger.”
RELX’s ongoing US lawsuit
Meanwhile in other news, a RELX shareholder has recently filed a US lawsuit against the manufacturer. The vape brand is being accused of not taking into account imminent Chinese regulations when applying for the US initial public offering (IPO) in October 2020.
The class action lawsuit was initiated in the US District Court for the Southern District of New York, by Investor Alex Garnett, who bought 300 shares at $27.87. He highlighted that together with other investors, he “sustained substantial damages in connection with their purchases of shares” in RELX Technology.
According to an article by ECigIntelligence, Garnett accused the manufacturer of failing to take into account the aim of Chinese regulators to tighten the regulations governing vaping products in the country, in their registration statement for the IPO. “RELX’s discussions of risk factors did not even mention, much less adequately describe the risk posed by, China’s ongoing effort to establish a national standard for e-cigarettes that would bring them into line with ordinary cigarette regulations,” reads the complaint, which calls for a jury trial.